(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
They died 'doing what they loved': The stories of workers in their 80s who died on the job - 22 new malaria treatments announced as drug resistance grows
- 3Volcanic eruption led to the Black Death, new research suggests
- 4Instructions to Upgrade the Mechanical Highlights of Your Shrewd Bed for a Superior Night's Rest
- 5Desired Travel Objections Worldwide: Where to Go Straightaway
- My daughter is in the #1 movie in the country. She still has to finish her math homework.
- 'Pluribus' release date: Everything you need to know about the new series from 'Better Call Saul's' co-creator
- Astounding Treehouses All over the Planet
- Step by step instructions to Contrast Lab Precious stones and Normal Jewels
- Executed Iranian nuclear scientist confessed to aiding Israel after torture, threats against mother
- The Force of Systems administration: Individual Examples of overcoming adversity
- 6 Objections for an Ocean side Wedding
- The Specialty of Cleaning up: Change Your Space and Brain
- One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes.
